These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 8995005

  • 1. Use of transdermal oestradiol (Estraderm TTS) in hypertensive postmenopausal women.
    Foidart JM.
    Br J Clin Pract Suppl; 1996 Sep; 86():14-6. PubMed ID: 8995005
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomised study to compare the efficacy and safety of new 17 beta-oestradiol transdermal matrix patch with Estraderm TTS 50 in hysterectomised postmenopausal women. The Lyrelle Study Group.
    al-Azzawi F, Van der Mooren MJ, Rolland R, Hirvonen E.
    Br J Clin Pract; 1997 Sep; 51(1):20-3, 25-6. PubMed ID: 9158267
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of weekly transdermal estradiol controlled delivery system in postmenopausal Chinese.
    Chen GS, Zhang MY, Wang Q, Ye JC.
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):407-10. PubMed ID: 9863160
    [Abstract] [Full Text] [Related]

  • 5. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
    Modena MG, Rossi R, Muia N, Origliani G, Rombolà O, Molinari R.
    G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776
    [Abstract] [Full Text] [Related]

  • 6. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S, Grady D, Quan J, Vittinghoff E, Wallace R, Hanes V, Ensrud K.
    Menopause; 2006 Jun; 13(1):130-8. PubMed ID: 16607109
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Postmenopausal hormone replacement therapy and insulin metabolism: effects of route of administration and implications for heart disease and diabetes risk.
    Godsland IF, Stevenson JC.
    Br J Clin Pract Suppl; 1996 Sep; 86():1-5. PubMed ID: 8995002
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F, Terek MC, Karadadaş N, Bilgin O.
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [Abstract] [Full Text] [Related]

  • 11. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B, Pressman A, Bradley C.
    Menopause; 1998 Nov; 5(3):152-6. PubMed ID: 9774760
    [Abstract] [Full Text] [Related]

  • 12. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H, Altunyurt S, Acar B, Fadiloglu M, Kirkali G, Onvural B.
    Maturitas; 2005 Apr 11; 50(4):289-93. PubMed ID: 15780528
    [Abstract] [Full Text] [Related]

  • 13. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
    O'Sullivan AJ, Crampton LJ, Freund J, Ho KK.
    J Clin Invest; 1998 Sep 01; 102(5):1035-40. PubMed ID: 9727072
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
    Maffei S, Del Ry S, Prontera C, Clerico A.
    Clin Sci (Lond); 2001 Nov 01; 101(5):447-53. PubMed ID: 11672449
    [Abstract] [Full Text] [Related]

  • 16. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E, Holinka CF, Arrenbrecht S.
    Int J Fertil Womens Med; 1997 Nov 01; 42 Suppl 2():388-98. PubMed ID: 9397386
    [Abstract] [Full Text] [Related]

  • 17. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec 01; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G, Ozmen B, Erguder I.
    Maturitas; 2006 Jan 10; 53(1):32-8. PubMed ID: 16325022
    [Abstract] [Full Text] [Related]

  • 20. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
    Wilcox JG, Hatch IE, Gentzschein E, Stanczyk FZ, Lobo RA.
    Fertil Steril; 1997 Feb 10; 67(2):273-7. PubMed ID: 9022602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.